Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy21 human cellular and mouse models
Yixing Wu, Karen Cleverley, Frances K. Wiseman
The paper investigates the effect of reducing Cystatin B on Cathepsin B activity in trisomy 21 models, finding increased activity in disomic controls but not in trisomy 21 conditions.